市場調査レポート

商品コード

1446412

腸溶性ソフトジェルカプセルの市場：用途別、流通チャネル別：世界の機会分析と産業予測、2023-2032年

Enteric Softgel Capsules Market By Application (Health Supplements, Pharmaceuticals), By Distribution Channel (Supermarket and Hypermarket, Pharmacy and Drug store, Online Provider): Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日: 2024年01月30日 | 発行: Allied Market Research

| ページ情報: 英文 250 Pages | 納期: 2～3営業日

価格

Cloud Access (Single User License)

USD 3,570 560,989円

レポートのクラウドアクセスでご利用頂けるライセンスです。ウェブポータルで配信され、60日間レポートにアクセスできます。この期間を過ぎるとレポートへのアクセスは失効します。コンテンツのダウンロード、印刷、共有、コピー＆ペーストはできません。

PDF (Business License)

USD 5,730 900,412円

レポートPDFをご利用いただけるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDFl内のテキスト等のコピー＆ペーストは可能です。印刷は5回可能です。追加料金を支払うことで、2～5ユーザーを収容できるようにアップグレードできます。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,600 1,508,544円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

腸溶性ソフトジェルカプセル市場の成長は、栄養補助食品サプリメントの採用急増と、腸溶性コーティングソフトジェルカプセルに関連する利点によって強く牽引されています。

健康志向の高まりに伴い、栄養補助食品の需要は増加傾向にあり、栄養補助食品産業の堅調な拡大に寄与しています。腸溶性ソフトジェルカプセルは、精密に調整された腸溶性コーティングによって区別され、デリケートな有効成分を胃の過酷な酸性条件から守りながら送達するための戦略的ソリューションとして登場しました。この標的放出メカニズムは腸での吸収を最適化し、医薬品や栄養素の生物学的利用能（バイオアベイラビリティ）を高めます。腸溶性ソフトジェルカプセルは、デリケートな製剤に適応できるため、健康増進化合物を効果的かつ効率的に送達することを目的とする製造業者にとって好ましい選択肢となります。

さらに、腸溶性コーティングソフトジェルカプセルのメリットは、患者のコンプライアンスを向上させ、胃腸の不快感の発生を効果的に減少させることにも及ぶ。副作用を軽減する能力は、サプリメントや医薬品の全体的な忍容性を高め、一貫した使用を促進します。さらに、腸溶性ソフトジェルカプセルは多様な製剤に適応できるため、医薬品や栄養補助食品の用途でさらに人気が高まっています。拡大する栄養補助食品分野と腸溶性コーティングソフトジェルカプセル固有の利点は、シームレスに相乗効果を発揮し、効能が高く忍容性の高い健康ソリューションを求める健康志向の消費者の嗜好の進化による市場の成長を反映しています。

利害関係者にとっての主なメリット

当レポートは、2022年から2032年までの腸溶性ソフトジェルカプセル市場分析の市場セグメント、現在の動向、推定・動向、力学の定量分析を提供し、腸溶性ソフトジェルカプセル市場の有力な市場機会を特定します。
市場促進要因、市場抑制要因、市場機会に関連する情報とともに市場調査を提供します。
ポーターのファイブフォース分析では、利害関係者が利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるように、バイヤーとサプライヤーの潜在力を強調します。
腸溶性ソフトジェルカプセルの市場セグメンテーションを詳細に分析することで、市場機会を見極めることができます。
各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。
市場企業のポジショニングは、ベンチマーキングを容易にし、市場企業の現在のポジションの明確な理解を提供します。
本レポートには、地域別および世界の腸溶性ソフトジェルカプセル市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析が含まれています。

本レポートのカスタマイズが可能です（追加費用とスケジュールが必要です。）

規制ガイドライン
顧客の関心に応じた企業プロファイルの追加
国別または地域別の追加分析-市場規模と予測
企業プロファイルの拡張リスト
過去の市場データ
主要企業の詳細（所在地、連絡先、サプライヤー／ベンダーネットワークなどを含む、エクセル形式）

概要
北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- その他
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- その他
ラテンアメリカ
- ブラジル
- コロンビア
- アルゼンチン
- その他のラテンアメリカ
中東・アフリカ
- Gcc
- 南アフリカ
- 北アフリカ
- その他

第7章競合情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合ヒートマップ
主要企業のポジショニング、2022年

第8章企業プロファイル

Catalent, Inc.
sirio pharma co., ltd.
Fuji Capsules Co. Ltd.
InovoBiologic Inc
NOW Foods Inc.
Gelita AG.
Captek Softgel International Inc.
Viva Pharmaceuticals
aenova group
Procaps Group

図表

LIST OF TABLES

TABLE 01. GLOBAL ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 02. ENTERIC SOFTGEL CAPSULES MARKET FOR HEALTH SUPPLEMENTS, BY REGION, 2022-2032 ($MILLION)
TABLE 03. ENTERIC SOFTGEL CAPSULES MARKET FOR PHARMACEUTICALS, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 05. ENTERIC SOFTGEL CAPSULES MARKET FOR SUPERMARKET AND HYPERMARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 06. ENTERIC SOFTGEL CAPSULES MARKET FOR PHARMACY AND DRUG STORE, BY REGION, 2022-2032 ($MILLION)
TABLE 07. ENTERIC SOFTGEL CAPSULES MARKET FOR ONLINE PROVIDER, BY REGION, 2022-2032 ($MILLION)
TABLE 08. ENTERIC SOFTGEL CAPSULES MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 09. NORTH AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 10. NORTH AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 11. NORTH AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 12. U.S. ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 13. U.S. ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 14. CANADA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 15. CANADA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 16. MEXICO ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 17. MEXICO ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 18. EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 19. EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 20. EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 21. GERMANY ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 22. GERMANY ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 23. FRANCE ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 24. FRANCE ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 25. UK ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 26. UK ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 27. ITALY ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 28. ITALY ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 29. SPAIN ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 30. SPAIN ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 31. REST OF EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 32. REST OF EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 33. ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 34. ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 35. ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 36. JAPAN ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 37. JAPAN ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 38. CHINA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 39. CHINA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 40. INDIA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 41. INDIA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 42. AUSTRALIA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 43. AUSTRALIA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 44. SOUTH KOREA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 45. SOUTH KOREA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 46. REST OF ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 47. REST OF ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 48. LATIN AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 49. LATIN AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 50. LATIN AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 51. BRAZIL ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 52. BRAZIL ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 53. COLOMBIA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 54. COLOMBIA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 55. ARGENTINA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 56. ARGENTINA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 57. REST OF LA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 58. REST OF LA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 59. MIDDLE EAST AND AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 60. MIDDLE EAST AND AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 61. MIDDLE EAST AND AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 62. GCC ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 63. GCC ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 64. SOUTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 65. SOUTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 66. NORTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 67. NORTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 68. REST OF MEA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 69. REST OF MEA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 70. CATALENT, INC.: KEY EXECUTIVES
TABLE 71. CATALENT, INC.: COMPANY SNAPSHOT
TABLE 72. CATALENT, INC.: PRODUCT SEGMENTS
TABLE 73. CATALENT, INC.: SERVICE SEGMENTS
TABLE 74. CATALENT, INC.: PRODUCT PORTFOLIO
TABLE 75. CATALENT, INC.: KEY STRATERGIES
TABLE 76. SIRIO PHARMA CO., LTD.: KEY EXECUTIVES
TABLE 77. SIRIO PHARMA CO., LTD.: COMPANY SNAPSHOT
TABLE 78. SIRIO PHARMA CO., LTD.: PRODUCT SEGMENTS
TABLE 79. SIRIO PHARMA CO., LTD.: SERVICE SEGMENTS
TABLE 80. SIRIO PHARMA CO., LTD.: PRODUCT PORTFOLIO
TABLE 81. SIRIO PHARMA CO., LTD.: KEY STRATERGIES
TABLE 82. FUJI CAPSULES CO. LTD.: KEY EXECUTIVES
TABLE 83. FUJI CAPSULES CO. LTD.: COMPANY SNAPSHOT
TABLE 84. FUJI CAPSULES CO. LTD.: PRODUCT SEGMENTS
TABLE 85. FUJI CAPSULES CO. LTD.: SERVICE SEGMENTS
TABLE 86. FUJI CAPSULES CO. LTD.: PRODUCT PORTFOLIO
TABLE 87. FUJI CAPSULES CO. LTD.: KEY STRATERGIES
TABLE 88. INOVOBIOLOGIC INC: KEY EXECUTIVES
TABLE 89. INOVOBIOLOGIC INC: COMPANY SNAPSHOT
TABLE 90. INOVOBIOLOGIC INC: PRODUCT SEGMENTS
TABLE 91. INOVOBIOLOGIC INC: SERVICE SEGMENTS
TABLE 92. INOVOBIOLOGIC INC: PRODUCT PORTFOLIO
TABLE 93. INOVOBIOLOGIC INC: KEY STRATERGIES
TABLE 94. NOW FOODS INC.: KEY EXECUTIVES
TABLE 95. NOW FOODS INC.: COMPANY SNAPSHOT
TABLE 96. NOW FOODS INC.: PRODUCT SEGMENTS
TABLE 97. NOW FOODS INC.: SERVICE SEGMENTS
TABLE 98. NOW FOODS INC.: PRODUCT PORTFOLIO
TABLE 99. NOW FOODS INC.: KEY STRATERGIES
TABLE 100. GELITA AG.: KEY EXECUTIVES
TABLE 101. GELITA AG.: COMPANY SNAPSHOT
TABLE 102. GELITA AG.: PRODUCT SEGMENTS
TABLE 103. GELITA AG.: SERVICE SEGMENTS
TABLE 104. GELITA AG.: PRODUCT PORTFOLIO
TABLE 105. GELITA AG.: KEY STRATERGIES
TABLE 106. CAPTEK SOFTGEL INTERNATIONAL INC.: KEY EXECUTIVES
TABLE 107. CAPTEK SOFTGEL INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 108. CAPTEK SOFTGEL INTERNATIONAL INC.: PRODUCT SEGMENTS
TABLE 109. CAPTEK SOFTGEL INTERNATIONAL INC.: SERVICE SEGMENTS
TABLE 110. CAPTEK SOFTGEL INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 111. CAPTEK SOFTGEL INTERNATIONAL INC.: KEY STRATERGIES
TABLE 112. VIVA PHARMACEUTICALS: KEY EXECUTIVES
TABLE 113. VIVA PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 114. VIVA PHARMACEUTICALS: PRODUCT SEGMENTS
TABLE 115. VIVA PHARMACEUTICALS: SERVICE SEGMENTS
TABLE 116. VIVA PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 117. VIVA PHARMACEUTICALS: KEY STRATERGIES
TABLE 118. AENOVA GROUP: KEY EXECUTIVES
TABLE 119. AENOVA GROUP: COMPANY SNAPSHOT
TABLE 120. AENOVA GROUP: PRODUCT SEGMENTS
TABLE 121. AENOVA GROUP: SERVICE SEGMENTS
TABLE 122. AENOVA GROUP: PRODUCT PORTFOLIO
TABLE 123. AENOVA GROUP: KEY STRATERGIES
TABLE 124. PROCAPS GROUP: KEY EXECUTIVES
TABLE 125. PROCAPS GROUP: COMPANY SNAPSHOT
TABLE 126. PROCAPS GROUP: PRODUCT SEGMENTS
TABLE 127. PROCAPS GROUP: SERVICE SEGMENTS
TABLE 128. PROCAPS GROUP: PRODUCT PORTFOLIO
TABLE 129. PROCAPS GROUP: KEY STRATERGIES

LIST OF FIGURES

FIGURE 01. ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF ENTERIC SOFTGEL CAPSULES MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN ENTERIC SOFTGEL CAPSULES MARKET
FIGURE 04. TOP INVESTMENT POCKETS IN ENTERIC SOFTGEL CAPSULES MARKET (2023-2032)
FIGURE 05. BARGAINING POWER OF SUPPLIERS
FIGURE 06. BARGAINING POWER OF BUYERS
FIGURE 07. THREAT OF SUBSTITUTION
FIGURE 08. THREAT OF SUBSTITUTION
FIGURE 09. COMPETITIVE RIVALRY
FIGURE 10. GLOBAL ENTERIC SOFTGEL CAPSULES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ENTERIC SOFTGEL CAPSULES MARKET FOR HEALTH SUPPLEMENTS, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ENTERIC SOFTGEL CAPSULES MARKET FOR PHARMACEUTICALS, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ENTERIC SOFTGEL CAPSULES MARKET FOR SUPERMARKET AND HYPERMARKET, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ENTERIC SOFTGEL CAPSULES MARKET FOR PHARMACY AND DRUG STORE, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ENTERIC SOFTGEL CAPSULES MARKET FOR ONLINE PROVIDER, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. ENTERIC SOFTGEL CAPSULES MARKET BY REGION, 2022 AND 2032(%)
FIGURE 19. U.S. ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 20. CANADA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 21. MEXICO ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 22. GERMANY ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 23. FRANCE ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 24. UK ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 25. ITALY ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 26. SPAIN ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 27. REST OF EUROPE ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 28. JAPAN ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 29. CHINA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 30. INDIA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 31. AUSTRALIA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 32. SOUTH KOREA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 33. REST OF ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 34. BRAZIL ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 35. COLOMBIA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 36. ARGENTINA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 37. REST OF LA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 38. GCC ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 39. SOUTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 40. NORTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 41. REST OF MEA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 45. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 46. COMPETITIVE DASHBOARD
FIGURE 47. COMPETITIVE HEATMAP: ENTERIC SOFTGEL CAPSULES MARKET
FIGURE 48. TOP PLAYER POSITIONING, 2022

Product Code: A02601

The growth of the enteric softgel capsules market is strongly driven by the surging adoption of nutraceutical supplements and the benefits associated with enteric-coated softgel capsules. With an escalating focus on health, the demand for nutritional supplements is on the rise, contributing to the robust expansion of the nutraceutical industry. Enteric softgel capsules, distinguished by their precisely tailored enteric coatings, emerge as a strategic solution for delivering delicate active ingredients, safeguarding them from the harsh acidic conditions of the stomach. This targeted release mechanism optimizes absorption in the intestine, thereby elevating the bioavailability of pharmaceuticals and nutrients.The adaptability of enteric softgel capsules to delicate formulations positions them as a preferred choice for manufacturers aiming to ensure the effective and efficient delivery of health-enhancing compounds.

In addition, the merits of enteric-coated softgel capsules extend to enhanced patient compliance, effectively reducing the incidence of gastrointestinal discomfort. The capacity to mitigate side effects fosters greater overall tolerability of supplements and medications, promoting consistent usage. Furthermore, the adaptability of enteric softgel capsules to a diverse array of formulations further propels their popularity across pharmaceutical and nutraceutical applications. The expanding nutraceutical sector and the inherent advantages of enteric-coated softgel capsules synergize seamlessly, reflecting market growth driven by the evolving preferences of health-conscious consumers seeking efficacious and well-tolerated health solutions.

The enteric softgel capsules market is segmented on the basis of application, distribution channel, and region. On the basis of application, the market is segmented into health supplements and pharmaceuticals. On the basis of distribution channel, the market is segmented supermarket & hypermarket, pharmacy & drug store, and online provider. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LA (Brazil, Colombia, Argentina, and rest of LA) and MEA (GCC, South Africa, North Africa and rest of MEA).

The major key players that operate in the global enteric softgel capsules market are Catalent, Inc., Sirio Pharma Co., Ltd., Fuji Capsules Co. Ltd., InovoBiologic Inc, NOW Foods Inc., Gelita AG, CAPTEK Softgel International Inc., Viva Pharmaceutical., Aenova Group, Procaps Group. The key players have adopted product launch as the key strategy to expand their product portfolio.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the enteric softgel capsules market analysis from 2022 to 2032 to identify the prevailing enteric softgel capsules market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the enteric softgel capsules market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global enteric softgel capsules market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Application

Health Supplements
Pharmaceuticals

By Distribution Channel

Supermarket and Hypermarket
Pharmacy and Drug store
Online Provider

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Colombia
- Argentina
- Rest Of La
Middle East and Africa
- Gcc
- South Africa
- North Africa
- Rest Of Mea

Key Market Players:

Catalent, Inc.
sirio pharma co., ltd.
Fuji Capsules Co. Ltd.
InovoBiologic Inc
NOW Foods Inc.
Gelita AG.
Captek Softgel International Inc.
Viva Pharmaceuticals
aenova group
Procaps Group

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Health Supplements
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Pharmaceuticals
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country

CHAPTER 5: ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Supermarket and Hypermarket
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Pharmacy and Drug store
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Online Provider
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country

CHAPTER 6: ENTERIC SOFTGEL CAPSULES MARKET, BY REGION

6.1. Overview
- 6.1.1. Market size and forecast By Region
6.2. North America
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by Application
- 6.2.3. Market size and forecast, by Distribution Channel
- 6.2.4. Market size and forecast, by country
  - 6.2.4.1. U.S.
  - 6.2.4.1.1. Market size and forecast, by Application
  - 6.2.4.1.2. Market size and forecast, by Distribution Channel
  - 6.2.4.2. Canada
  - 6.2.4.2.1. Market size and forecast, by Application
  - 6.2.4.2.2. Market size and forecast, by Distribution Channel
  - 6.2.4.3. Mexico
  - 6.2.4.3.1. Market size and forecast, by Application
  - 6.2.4.3.2. Market size and forecast, by Distribution Channel
6.3. Europe
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by Application
- 6.3.3. Market size and forecast, by Distribution Channel
- 6.3.4. Market size and forecast, by country
  - 6.3.4.1. Germany
  - 6.3.4.1.1. Market size and forecast, by Application
  - 6.3.4.1.2. Market size and forecast, by Distribution Channel
  - 6.3.4.2. France
  - 6.3.4.2.1. Market size and forecast, by Application
  - 6.3.4.2.2. Market size and forecast, by Distribution Channel
  - 6.3.4.3. UK
  - 6.3.4.3.1. Market size and forecast, by Application
  - 6.3.4.3.2. Market size and forecast, by Distribution Channel
  - 6.3.4.4. Italy
  - 6.3.4.4.1. Market size and forecast, by Application
  - 6.3.4.4.2. Market size and forecast, by Distribution Channel
  - 6.3.4.5. Spain
  - 6.3.4.5.1. Market size and forecast, by Application
  - 6.3.4.5.2. Market size and forecast, by Distribution Channel
  - 6.3.4.6. Rest of Europe
  - 6.3.4.6.1. Market size and forecast, by Application
  - 6.3.4.6.2. Market size and forecast, by Distribution Channel
6.4. Asia-Pacific
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by Application
- 6.4.3. Market size and forecast, by Distribution Channel
- 6.4.4. Market size and forecast, by country
  - 6.4.4.1. Japan
  - 6.4.4.1.1. Market size and forecast, by Application
  - 6.4.4.1.2. Market size and forecast, by Distribution Channel
  - 6.4.4.2. China
  - 6.4.4.2.1. Market size and forecast, by Application
  - 6.4.4.2.2. Market size and forecast, by Distribution Channel
  - 6.4.4.3. India
  - 6.4.4.3.1. Market size and forecast, by Application
  - 6.4.4.3.2. Market size and forecast, by Distribution Channel
  - 6.4.4.4. Australia
  - 6.4.4.4.1. Market size and forecast, by Application
  - 6.4.4.4.2. Market size and forecast, by Distribution Channel
  - 6.4.4.5. South Korea
  - 6.4.4.5.1. Market size and forecast, by Application
  - 6.4.4.5.2. Market size and forecast, by Distribution Channel
  - 6.4.4.6. Rest of Asia-Pacific
  - 6.4.4.6.1. Market size and forecast, by Application
  - 6.4.4.6.2. Market size and forecast, by Distribution Channel
6.5. Latin America
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by Application
- 6.5.3. Market size and forecast, by Distribution Channel
- 6.5.4. Market size and forecast, by country
  - 6.5.4.1. Brazil
  - 6.5.4.1.1. Market size and forecast, by Application
  - 6.5.4.1.2. Market size and forecast, by Distribution Channel
  - 6.5.4.2. Colombia
  - 6.5.4.2.1. Market size and forecast, by Application
  - 6.5.4.2.2. Market size and forecast, by Distribution Channel
  - 6.5.4.3. Argentina
  - 6.5.4.3.1. Market size and forecast, by Application
  - 6.5.4.3.2. Market size and forecast, by Distribution Channel
  - 6.5.4.4. Rest Of La
  - 6.5.4.4.1. Market size and forecast, by Application
  - 6.5.4.4.2. Market size and forecast, by Distribution Channel
6.6. Middle East and Africa
- 6.6.1. Key market trends, growth factors and opportunities
- 6.6.2. Market size and forecast, by Application
- 6.6.3. Market size and forecast, by Distribution Channel
- 6.6.4. Market size and forecast, by country
  - 6.6.4.1. Gcc
  - 6.6.4.1.1. Market size and forecast, by Application
  - 6.6.4.1.2. Market size and forecast, by Distribution Channel
  - 6.6.4.2. South Africa
  - 6.6.4.2.1. Market size and forecast, by Application
  - 6.6.4.2.2. Market size and forecast, by Distribution Channel
  - 6.6.4.3. North Africa
  - 6.6.4.3.1. Market size and forecast, by Application
  - 6.6.4.3.2. Market size and forecast, by Distribution Channel
  - 6.6.4.4. Rest Of Mea
  - 6.6.4.4.1. Market size and forecast, by Application
  - 6.6.4.4.2. Market size and forecast, by Distribution Channel

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top winning strategies
7.3. Product mapping of top 10 player
7.4. Competitive dashboard
7.5. Competitive heatmap
7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

8.1. Catalent, Inc.
- 8.1.1. Company overview
- 8.1.2. Key executives
- 8.1.3. Company snapshot
- 8.1.4. Operating business segments
- 8.1.5. Product portfolio
- 8.1.6. Business performance
- 8.1.7. Key strategic moves and developments
8.2. sirio pharma co., ltd.
- 8.2.1. Company overview
- 8.2.2. Key executives
- 8.2.3. Company snapshot
- 8.2.4. Operating business segments
- 8.2.5. Product portfolio
- 8.2.6. Business performance
- 8.2.7. Key strategic moves and developments
8.3. Fuji Capsules Co. Ltd.
- 8.3.1. Company overview
- 8.3.2. Key executives
- 8.3.3. Company snapshot
- 8.3.4. Operating business segments
- 8.3.5. Product portfolio
- 8.3.6. Business performance
- 8.3.7. Key strategic moves and developments
8.4. InovoBiologic Inc
- 8.4.1. Company overview
- 8.4.2. Key executives
- 8.4.3. Company snapshot
- 8.4.4. Operating business segments
- 8.4.5. Product portfolio
- 8.4.6. Business performance
- 8.4.7. Key strategic moves and developments
8.5. NOW Foods Inc.
- 8.5.1. Company overview
- 8.5.2. Key executives
- 8.5.3. Company snapshot
- 8.5.4. Operating business segments
- 8.5.5. Product portfolio
- 8.5.6. Business performance
- 8.5.7. Key strategic moves and developments
8.6. Gelita AG.
- 8.6.1. Company overview
- 8.6.2. Key executives
- 8.6.3. Company snapshot
- 8.6.4. Operating business segments
- 8.6.5. Product portfolio
- 8.6.6. Business performance
- 8.6.7. Key strategic moves and developments
8.7. Captek Softgel International Inc.
- 8.7.1. Company overview
- 8.7.2. Key executives
- 8.7.3. Company snapshot
- 8.7.4. Operating business segments
- 8.7.5. Product portfolio
- 8.7.6. Business performance
- 8.7.7. Key strategic moves and developments
8.8. Viva Pharmaceuticals
- 8.8.1. Company overview
- 8.8.2. Key executives
- 8.8.3. Company snapshot
- 8.8.4. Operating business segments
- 8.8.5. Product portfolio
- 8.8.6. Business performance
- 8.8.7. Key strategic moves and developments
8.9. aenova group
- 8.9.1. Company overview
- 8.9.2. Key executives
- 8.9.3. Company snapshot
- 8.9.4. Operating business segments
- 8.9.5. Product portfolio
- 8.9.6. Business performance
- 8.9.7. Key strategic moves and developments
8.10. Procaps Group
- 8.10.1. Company overview
- 8.10.2. Key executives
- 8.10.3. Company snapshot
- 8.10.4. Operating business segments
- 8.10.5. Product portfolio
- 8.10.6. Business performance
- 8.10.7. Key strategic moves and developments

腸溶性ソフトジェルカプセルの市場：用途別、流通チャネル別：世界の機会分析と産業予測、2023-2032年

Enteric Softgel Capsules Market By Application (Health Supplements, Pharmaceuticals), By Distribution Channel (Supermarket and Hypermarket, Pharmacy and Drug store, Online Provider): Global Opportunity Analysis and Industry Forecast, 2023-2032

利害関係者にとっての主なメリット

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章腸溶性ソフトジェルカプセル市場：用途別

第5章腸溶性ソフトジェルカプセル市場：流通チャネル別

第6章腸溶性ソフトジェルカプセル市場：地域別

第7章競合情勢

第8章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By Application

By Distribution Channel

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION

CHAPTER 5: ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL

CHAPTER 6: ENTERIC SOFTGEL CAPSULES MARKET, BY REGION

CHAPTER 7: COMPETITIVE LANDSCAPE

CHAPTER 8: COMPANY PROFILES

腸溶性ソフトジェルカプセルの市場：用途別、流通チャネル別：世界の機会分析と産業予測、2023-2032年

Enteric Softgel Capsules Market By Application (Health Supplements, Pharmaceuticals), By Distribution Channel (Supermarket and Hypermarket, Pharmacy and Drug store, Online Provider): Global Opportunity Analysis and Industry Forecast, 2023-2032

利害関係者にとっての主なメリット

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

第4章 腸溶性ソフトジェルカプセル市場：用途別

第5章 腸溶性ソフトジェルカプセル市場：流通チャネル別

第6章 腸溶性ソフトジェルカプセル市場：地域別

第7章 競合情勢

第8章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By Application

By Distribution Channel

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION

CHAPTER 5: ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL

CHAPTER 6: ENTERIC SOFTGEL CAPSULES MARKET, BY REGION

CHAPTER 7: COMPETITIVE LANDSCAPE

CHAPTER 8: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章腸溶性ソフトジェルカプセル市場：用途別

第5章腸溶性ソフトジェルカプセル市場：流通チャネル別

第6章腸溶性ソフトジェルカプセル市場：地域別

第7章競合情勢

第8章企業プロファイル